Abstract
OBJECTIVE - Compare differences in health-related quality of life among blacks and whites to examine if race, diabetes, and visual impairment (VI) present a triple disadvantage in terms of quality-adjusted life expectancy. RESEARCH DESIGN AND METHODS - Data were analyzed fromthe 2000-2003 Medical Expenditure Panel Survey, a nationally representative survey that contains the EuroQol 5D (EQ-5D). The EQ-5D generates health utility values that provide a measure of the morbidity associated with various health states, such as having moderate or severe problems with mobility. The EQ-5D score can be linked with life expectancy data to calculate quality-adjusted life-years (QALYs), the number of years of optimal health an individual is expected to live. Multivariate analyses were conducted to estimate and compare differences in QALYs by diabetes status, VI status, and race. RESULTS - Whites had a higher quality-adjusted life expectancy across all diabetes/VI comparisons. Overall, blacks with diabetes and VI had the fewest number of QALYs remaining (19.6 years), and whites with no impairment had the greatest number ofQALYs remaining (31.6 years). Blacks with diabetes only had 1.7 fewer years of optimal health (fewer QALYs) than whites with diabetes. Within individuals with both diabetes and VI, however, this gap more than doubled, with blacks experiencing 3.5 fewer QALYs than whites. CONCLUSIONS - Although efforts to target and reduce racial health disparities associated with diabetes appear to be effective, black communities may be contributing to a greater overall burden of illness given poorer infrastructure and less accommodation for disabilities such as VI.
| Original language | English |
|---|---|
| Pages (from-to) | 1692-1694 |
| Number of pages | 3 |
| Journal | Diabetes Care |
| Volume | 35 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2012 |
Fingerprint
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Advanced and Specialized Nursing
Cite this
Racial disparities in quality-adjusted life-years associated with diabetes and visual impairment. / McCollister, Kathryn; Zheng, D. Diane; Fernandez, Cristina A.; Lee, David J; Lam, Byron L; Arheart, Kristopher; Galor, Anat; Ocasio, Manuel; Muennig, Peter.
In: Diabetes Care, Vol. 35, No. 8, 01.08.2012, p. 1692-1694.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Racial disparities in quality-adjusted life-years associated with diabetes and visual impairment
AU - McCollister, Kathryn
AU - Zheng, D. Diane
AU - Fernandez, Cristina A.
AU - Lee, David J
AU - Lam, Byron L
AU - Arheart, Kristopher
AU - Galor, Anat
AU - Ocasio, Manuel
AU - Muennig, Peter
PY - 2012/8/1
Y1 - 2012/8/1
N2 - OBJECTIVE - Compare differences in health-related quality of life among blacks and whites to examine if race, diabetes, and visual impairment (VI) present a triple disadvantage in terms of quality-adjusted life expectancy. RESEARCH DESIGN AND METHODS - Data were analyzed fromthe 2000-2003 Medical Expenditure Panel Survey, a nationally representative survey that contains the EuroQol 5D (EQ-5D). The EQ-5D generates health utility values that provide a measure of the morbidity associated with various health states, such as having moderate or severe problems with mobility. The EQ-5D score can be linked with life expectancy data to calculate quality-adjusted life-years (QALYs), the number of years of optimal health an individual is expected to live. Multivariate analyses were conducted to estimate and compare differences in QALYs by diabetes status, VI status, and race. RESULTS - Whites had a higher quality-adjusted life expectancy across all diabetes/VI comparisons. Overall, blacks with diabetes and VI had the fewest number of QALYs remaining (19.6 years), and whites with no impairment had the greatest number ofQALYs remaining (31.6 years). Blacks with diabetes only had 1.7 fewer years of optimal health (fewer QALYs) than whites with diabetes. Within individuals with both diabetes and VI, however, this gap more than doubled, with blacks experiencing 3.5 fewer QALYs than whites. CONCLUSIONS - Although efforts to target and reduce racial health disparities associated with diabetes appear to be effective, black communities may be contributing to a greater overall burden of illness given poorer infrastructure and less accommodation for disabilities such as VI.
AB - OBJECTIVE - Compare differences in health-related quality of life among blacks and whites to examine if race, diabetes, and visual impairment (VI) present a triple disadvantage in terms of quality-adjusted life expectancy. RESEARCH DESIGN AND METHODS - Data were analyzed fromthe 2000-2003 Medical Expenditure Panel Survey, a nationally representative survey that contains the EuroQol 5D (EQ-5D). The EQ-5D generates health utility values that provide a measure of the morbidity associated with various health states, such as having moderate or severe problems with mobility. The EQ-5D score can be linked with life expectancy data to calculate quality-adjusted life-years (QALYs), the number of years of optimal health an individual is expected to live. Multivariate analyses were conducted to estimate and compare differences in QALYs by diabetes status, VI status, and race. RESULTS - Whites had a higher quality-adjusted life expectancy across all diabetes/VI comparisons. Overall, blacks with diabetes and VI had the fewest number of QALYs remaining (19.6 years), and whites with no impairment had the greatest number ofQALYs remaining (31.6 years). Blacks with diabetes only had 1.7 fewer years of optimal health (fewer QALYs) than whites with diabetes. Within individuals with both diabetes and VI, however, this gap more than doubled, with blacks experiencing 3.5 fewer QALYs than whites. CONCLUSIONS - Although efforts to target and reduce racial health disparities associated with diabetes appear to be effective, black communities may be contributing to a greater overall burden of illness given poorer infrastructure and less accommodation for disabilities such as VI.
UR - http://www.scopus.com/inward/record.url?scp=84864380528&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864380528&partnerID=8YFLogxK
U2 - 10.2337/dc11-2433
DO - 10.2337/dc11-2433
M3 - Article
VL - 35
SP - 1692
EP - 1694
JO - Diabetes Care
JF - Diabetes Care
SN - 1935-5548
IS - 8
ER -